Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

By Sriparna Roy and Bhanvi Satija (Reuters) -Shares of global vaccine makers were muted on Tuesday as investors and analysts ...

MRK wins early FDA approval for RSV antibody Enflonsia in infants, with U.S. launch planned before the 2025-26 season.

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

Dividend stocks are one way to shield yourself from the market volatility. While all stocks carry a certain element of risk, ...

A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...

Shares of major vaccine makers Moderna and Pfizer held steady even as U.S. health secretary Robert F. Kennedy Jr. abruptly ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

The assessment of Crohn's disease activity through endoscopy is a cornerstone of both clinical management and research. In The Lancet Gastroenterology & Hepatology, Christopher Ma and colleagues ...

RNs working at UCSD Medical Center plan to rally Tuesday alongside UC nurses statewide to mark the start of their contract ...